BioNxt Solutions Inc. (FRA:BXT)
Germany
· Delayed Price · Currency is EUR 0.2940
-0.0160 (-5.16%)
At close: Apr 25, 2025, 10:00 PM CET
BioNxt Solutions Revenue
BioNxt Solutions had revenue of 17.10K CAD in the quarter ending September 30, 2024, with 198.55% growth. This brings the company's revenue in the last twelve months to 42.01K, down -89.20% year-over-year. In the year 2023, BioNxt Solutions had annual revenue of 372.25K with 25.15% growth.
Revenue (ttm)
42.01K CAD
Revenue Growth
-89.20%
P/S Ratio
1,186.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.07M EUR
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Siemens Energy AG | 35.76B |
| Merck KGaA | 21.16B |
BioNxt Solutions News
- 6 days ago - BioNxt Solutions Prepares for Human Bioequivalence Study For MS - Wallstreet:Online